In vitro selection of resistant Helicobacter pylori

Author:

Haas C E1,Nix D E1,Schentag J J1

Affiliation:

1. Center for Clinical Pharmacy Research, School of Pharmacy, State University of New York, Buffalo.

Abstract

Four strains of Helicobacter pylori were subjected to an in vitro serial passage technique to compare the propensity of the organisms to develop resistance to seven classes of antibacterial agents. The passages were made on serially doubling concentrations of antibacterial agents incorporated into agar starting at one-half the base-line MIC. The frequency of spontaneous resistance was also determined for each strain at four and eight times the MIC of each antibacterial agent. Strains resistant to ciprofloxacin, metronidazole, erythromycin, and tobramycin were isolated. The experiments failed to select organisms resistant to bismuth subsalicylate, furazolidone, or amoxicillin, although the MIC of amoxicillin was increased 4- to 16-fold. With the exception of erythromycin, organisms with the selected resistance were stable after at least three passages on antibacterial agent-free medium. Spontaneous resistance rates were generally of a low magnitude and were not predictive of the serial passage results.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Reference22 articles.

1. Barry A. L. 1986. Procedure for testing antimicrobial agents in agar media: theoretical considerations p. 1-26. In V. Lorian (ed.) Antibiotics in laboratory medicine 2nd ed. The Williams & Wilkins Co. Baltimore.

2. Chemotherapeutic properties of prominent nitrofurans;Chamberlain R. E.;J. Antimicrob. Chemother.,1976

3. Coghlan J. G. H. Humphries C. Dooley C. Keane D. Gilligan D. McKenna E. Sweeney and C. O'Morain. 1987. Campylobacter pylori and recurrence of duodenal ulcers-a 12-month follow-up study. Lancet ii:1109-1111.

4. The clinical significance of Campylobacter pylori;Dooley C. P.;Ann. Intern. Med.,1988

5. Campylobacter pylori-associated gastritis: a double-blind placebo-controlled trial with amoxycillin;Glupczynski Y.;Am. J. Gastroenterol.,1988

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3